133 related articles for article (PubMed ID: 27055469)
41. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
[TBL] [Abstract][Full Text] [Related]
42. A solid-in-oil-in-water emulsion: An adjuvant-based immune-carrier enhances vaccine effect.
Tahara Y; Mizuno R; Nishimura T; Mukai SA; Wakabayashi R; Kamiya N; Akiyoshi K; Goto M
Biomaterials; 2022 Mar; 282():121385. PubMed ID: 35093824
[TBL] [Abstract][Full Text] [Related]
43. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
Korsholm KS; Hansen J; Karlsen K; Filskov J; Mikkelsen M; Lindenstrøm T; Schmidt ST; Andersen P; Christensen D
Vaccine; 2014 Jun; 32(31):3927-35. PubMed ID: 24877765
[TBL] [Abstract][Full Text] [Related]
44. Preparation of Squalene Oil-Based Emulsion Adjuvants Employing a Self-Emulsifying Drug Delivery System and Assessment of
Bastola R; Seo JE; Keum T; Noh G; Choi JW; Shin JI; Kim JH; Lee S
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31835466
[TBL] [Abstract][Full Text] [Related]
45. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.
Coulter A; Wong TY; Drane D; Bates J; Macfarlan R; Cox J
Vaccine; 1998 Jul; 16(11-12):1243-53. PubMed ID: 9682385
[TBL] [Abstract][Full Text] [Related]
46. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products.
Iyer V; Cayatte C; Marshall JD; Sun J; Schneider-Ohrum K; Maynard SK; Rajani GM; Bennett AS; Remmele RL; Bishop SM; McCarthy MP; Muralidhara BK
J Pharm Sci; 2017 Jun; 106(6):1490-1498. PubMed ID: 28259764
[TBL] [Abstract][Full Text] [Related]
48. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
[TBL] [Abstract][Full Text] [Related]
49. Construction of a stable w/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine.
Chen Z; Zhang S; Li Z; Ma G; Su Z
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):897-906. PubMed ID: 27322345
[TBL] [Abstract][Full Text] [Related]
50. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.
Shah RR; Dodd S; Schaefer M; Ugozzoli M; Singh M; Otten GR; Amiji MM; O'Hagan DT; Brito LA
J Pharm Sci; 2015 Apr; 104(4):1352-61. PubMed ID: 25600347
[TBL] [Abstract][Full Text] [Related]
51. SEPPIC vaccine adjuvants for poultry.
Dupuis L; Ascarateil S; Aucouturier J; Ganne V
Ann N Y Acad Sci; 2006 Oct; 1081():202-5. PubMed ID: 17135512
[TBL] [Abstract][Full Text] [Related]
52. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
Karan D; Krieg AM; Lubaroff DM
Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
[TBL] [Abstract][Full Text] [Related]
53. Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice.
Yu S; Tang C; Shi X; Yang P; Xing L; Wang X
Vaccine; 2012 Aug; 30(36):5425-36. PubMed ID: 22709954
[TBL] [Abstract][Full Text] [Related]
54. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 1. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion.
Kimura J; Nariuchi H; Watanabe T; Matuhasi T; Okayasu I; Hatakeyama S
Jpn J Exp Med; 1978 Apr; 48(2):149-54. PubMed ID: 713123
[TBL] [Abstract][Full Text] [Related]
55. Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants.
Du C; Nilsson S; Lu H; Yin J; Jiang N; Wahlgren M; Chen Q
Vaccine; 2010 Jul; 28(31):4977-83. PubMed ID: 20653104
[TBL] [Abstract][Full Text] [Related]
56. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
57. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
Kakimi K; Isobe M; Uenaka A; Wada H; Sato E; Doki Y; Nakajima J; Seto Y; Yamatsuji T; Naomoto Y; Shiraishi K; Takigawa N; Kiura K; Tsuji K; Iwatsuki K; Oka M; Pan L; Hoffman EW; Old LJ; Nakayama E
Int J Cancer; 2011 Dec; 129(12):2836-46. PubMed ID: 21448901
[TBL] [Abstract][Full Text] [Related]
58. Enhancing immune responses to inactivated porcine parvovirus oil emulsion vaccine by co-inoculating porcine transfer factor in mice.
Wang RN; Wang YB; Geng JW; Guo DH; Liu F; Chen HY; Zhang HY; Cui BA; Wei ZY
Vaccine; 2012 Jul; 30(35):5246-52. PubMed ID: 22705080
[TBL] [Abstract][Full Text] [Related]
59. Montanideâ„¢ ISA 71 VG adjuvant enhances antibody and cell-mediated immune responses to profilin subunit antigen vaccination and promotes protection against Eimeria acervulina and Eimeria tenella.
Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Bertrand F; Dupuis L; Deville S
Exp Parasitol; 2011 Jan; 127(1):178-83. PubMed ID: 20728439
[TBL] [Abstract][Full Text] [Related]
60. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]